The positive results put general research priority on CCL2 signaling and can be of value for other lung diseases of all ages and beyond where activation of the CCL2/CCR2 axis is a hallmark event of disease pathology as described for example in influenza virus infection, cystic fibrosis and pulmonary fibrosis [49–51]. This evidence concerns the gene CCL2 and cystic fibrosis.